Patents by Inventor Jay Trivedi

Jay Trivedi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210196718
    Abstract: The present invention relates to compounds and pharmaceutical composition having antiviral effects. Over 1200 molecules were screened and 55 molecules having statistically significant anti-HIV activity were identified and selected. The compound Methotrexate (MTX-HYD) and its analogues, the combinations thereof and their combination with other anti-retrovirals were selected for repurposing the compounds as anti-HIV drugs. The present invention may further relate to pharmaceutical composition comprising compounds in combination with active drugs having anti-HIV activity.
    Type: Application
    Filed: May 10, 2019
    Publication date: July 1, 2021
    Inventors: Debashis MITRA, Jay TRIVEDI
  • Publication number: 20070009591
    Abstract: A process for preparing pharmaceutical micro-tablets comprises (a) preparing a tableting mix that comprises an ACE inhibitor, for example moexipril hydrochloride, and excipient ingredients that comprise one or more lubricants; and (b) compressing the tableting mix in a tablet press, to form micro-tablets having an average uncoated weight of about 1 to about 40 mg; wherein the process employs means for promoting release of the mirco-tablets from the tablet press, said release promoting means being unnecessary for otherwise similar standard tablets having an average uncoated weight greater than about 50 mg. A plurality of micro-tablets thus prepared, collectively comprising a therapeutically effective amount of the ACE inhibitor, can be filled into a pharmaceutically acceptable capsule shell to provide a dosage form.
    Type: Application
    Filed: July 7, 2005
    Publication date: January 11, 2007
    Inventors: Jay Trivedi, Gaetan Marcoux
  • Publication number: 20050090543
    Abstract: Among its several embodiments, the present invention provides an improved process for the preparation of tetrahydrobenzothiepine-1,1-dioxide compounds; the provision of a process for preparing a diastereomeric mixture of tetrahydrobenzothiepine-1,1-dioxide compounds from a single diastereomer of such compounds; the provision of a process for the preparation of 3-bromo-2-substituted propionaldehyde compounds; and the provision of a process for the preparation of 3-thio-2-substituted propionaldehyde compounds.
    Type: Application
    Filed: May 19, 2004
    Publication date: April 28, 2005
    Applicant: Pharmacia Corporation
    Inventors: Kevin Babiak, Andrew Carpenter, Shine Chou, Pierre-Jean Colson, Farid Payman, Robert Hett, Christian Huber, Kevin Koeller, Jon Lawson, James Li, Eduardo Mar, Lawrence Miller, Vladislav Orlovski, James Peterson, Mark Pozzo, Claire Przybyla, Samuel Tremont, Jay Trivedi, Grace Wagner, Gerald Weisenburger, Benxin Zhi
  • Publication number: 20050013856
    Abstract: A pharmaceutical composition is provided comprising a drug and a carrier medium, wherein the carrier medium comprisese (a) a matrix forming agent selected from the group consisting of hydroxyethylcelluloses, hydroxypropylcelluloses, hydroxypropylmethylcelluloses, hydroxypropylmethylcellulose phthalates, polyvinylpyrrolidones, polyethylene glycols, polyglycolized glycerides, cyclodextrins, carbomers and combinations thereof, and (b) a filler; and wherein the drug is hygroscopic and/or deliquescent and is dispersed in the carrier medium, and wherein the composition is a solid dispersion and is acceptably non-hygroscopic.
    Type: Application
    Filed: December 18, 2003
    Publication date: January 20, 2005
    Inventors: Jay Trivedi, Rajeev Gokhale